A meta viewonmeta-analyses

JAMA Psychiatry

Volumn 74, Issue 7, 2017, Pages 684-685

  Fleischhacker, W Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

AMBIGUITY; DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS (TOPIC); MONOTHERAPY; NOTE; PUBLISHING; QUALITY CONTROL; SAMPLE SIZE; SCHIZOPHRENIA; TREATMENT-RESISTANT SCHIZOPHRENIA; MULTIMODALITY CANCER THERAPY;

ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; SCHIZOPHRENIA;

EID: 85024089342     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2017.1167     Document Type: Note

References (9)

1. Correll CU, Rubio JM, Inczedy-Farkas G, et al. Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence [published online May 17, 2017]. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2017.0624
2. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: ameta-analysis of randomized controlled trials. Schizophr Bull. 2009; 35(2):443-457
3. Murad MH, Montori VM, Ioannidis JPA, et al. How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature. JAMA. 2014;312(2):171-179
4. Adams CE, Fenton MK, Quraishi S, David AS. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry. 2001;179:290-299
5. Leucht C, Heres S, Kane JM, KisslingW, Davis JM, Leucht S. Oral versus depot antipsychotic drugs for schizophrenia-a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res. 2011;127(1-3):83-92
6. Kishimoto T, Robenzadeh A, Leucht C, et al. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: ameta-analysis of randomized trials. Schizophr Bull. 2014;40(1):192-213
7. Kishimoto T, Nitta M, Borenstein M, Kane JM, Correll CU. Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies. J Clin Psychiatry. 2013;74(10):957-965
8. SamaraMT, Dold M, Gianatsi M, et al. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry. 2016;73(3):199-210
9. Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016;209(5): 385-392